MedPath

VALLEY RETINA INSTITUTE

🇺🇸United States
Ownership
-
Established
1995-01-01
Employees
-
Market Cap
-
Website
http://www.valleyretinainstitute.com/

Clinical Trials

4

Active:0
Completed:1

Trial Phases

2 Phases

Phase 2:1
Phase 4:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 4
3 (75.0%)
Phase 2
1 (25.0%)

Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN

Phase 2
Conditions
Proliferative Diabetic Retinopathy
Interventions
First Posted Date
2015-12-15
Last Posted Date
2015-12-15
Lead Sponsor
Valley Retina Institute
Target Recruit Count
30
Registration Number
NCT02630277

Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion

Phase 4
Conditions
Macular Edema
Central Retinal Vein Occlusion
Interventions
Drug: Combination Ozurdex with Ranibizumab PRN
First Posted Date
2013-04-10
Last Posted Date
2015-12-14
Lead Sponsor
Valley Retina Institute
Target Recruit Count
45
Registration Number
NCT01827722
Locations
🇺🇸

Retina Vitreous Associates Medical Group, Beverly Hills, California, United States

🇺🇸

Retina Associates, Lakeland, Florida, United States

🇺🇸

Center for Retina and Macular Disease, Winter Haven, Florida, United States

and more 1 locations

Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study

Phase 4
Completed
Conditions
Diabetic Macular Edema
Interventions
First Posted Date
2011-12-06
Last Posted Date
2013-07-16
Lead Sponsor
Valley Retina Institute
Target Recruit Count
72
Registration Number
NCT01486238
Locations
🇺🇸

Valley Retina Institute,PA, McAllen, Texas, United States

Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)

Phase 4
Conditions
Proliferative Diabetic Retinopathy
Interventions
Drug: Macugen ® (pegaptanib sodium)
First Posted Date
2011-12-06
Last Posted Date
2011-12-06
Lead Sponsor
Valley Retina Institute
Target Recruit Count
30
Registration Number
NCT01486771
Locations
🇺🇸

Valley Retina Insitute, PA, McAllen, Texas, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath